Sound Pharmaceuticals, Inc.

📍 Seattle, United States👥 13 employees💰 Last funded Sep 2013
Pharmaceutical Manufacturing🌐 soundpharmaceuticals.com
Website LinkedIn
Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss. Sensorineural hearing loss is the third largest disease in the industrialized world and affects 50 million Americans. Estimates from the NIH and the CDC place the total annual costs of hearing loss at approximately $50 billion per year in the U.S. alone.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sound Pharmaceuticals, Inc.?
Sound Pharmaceuticals, Inc. has 1 investors on record on gritt.io.
When did Sound Pharmaceuticals, Inc. last raise funding?
The most recent investment in Sound Pharmaceuticals, Inc. recorded on gritt.io was in September 2013.
What industry is Sound Pharmaceuticals, Inc. in?
Sound Pharmaceuticals, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sound Pharmaceuticals, Inc. based?
Sound Pharmaceuticals, Inc. is headquartered in Seattle, United States.